Biotech18 hours ago
Breakthrough Advances at ESMO 2025 Redefine Breast Cancer Treatment with Targeted and ADC Therapies
At ESMO 2025, new data marked a major advance in breast cancer treatment. ADCs like trastuzumab deruxtecan and datopotamab deruxtecan significantly improved survival and reduced relapse...